Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of local and systemic antimicrobials on leukocyte- and platelet rich fibrin: an in vitro study.

Scientific reports·2022
Same author

Prospective international validation of the predisposition, infection, response and organ dysfunction (PIRO) clinical staging system among intensive care and general ward patients.

Annals of intensive care·2021
Same author

The effect of agricultural intensification and water-locking on the world's largest coastal lagoonal system.

The Science of the total environment·2021
Same author

Impact of g force and timing on the characteristics of platelet-rich fibrin matrices.

Scientific reports·2021
Same author

Background levels of trace elements in brown and red seaweeds from Trindade, a remote island in South Atlantic Ocean.

Marine pollution bulletin·2018
Same author

Diazoxide enhances excitotoxicity-induced neurogenesis and attenuates neurodegeneration in the rat non-neurogenic hippocampus.

Neuroscience·2016

Related Experiment Video

Updated: Jun 3, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

Multiple drug interaction across medical specializations.

C Andrade1

  • 1M.D., Additional Professor & Head, Department of Psychopharmacology, National Institute of Mental Health and Neurosciences, Bangalore 560 029, India.

Indian Journal of Psychiatry
|April 2, 2011
PubMed
Summary

Drug interactions can cause serious side effects. A patient on carbamazepine developed neurotoxicity after taking erythromycin and ketoconazole, highlighting the need for careful medication review across specialties.

Keywords:
Carbamazepinedrug interactionerythromycinketoconazolemetabolic interactionsneurotoxicitypharmacokinetic interactions

More Related Videos

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

Related Experiment Videos

Last Updated: Jun 3, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

Area of Science:

  • Pharmacology
  • Clinical Toxicology
  • Neuroscience

Background:

  • Carbamazepine is an antiepileptic drug often used as monotherapy.
  • Drug interactions can alter the pharmacokinetics and pharmacodynamics of medications.
  • Polypharmacy increases the risk of adverse drug events, especially in patients with chronic conditions.

Purpose of the Study:

  • To report a case of carbamazepine-induced neurotoxicity.
  • To investigate the pharmacokinetic interaction between carbamazepine, erythromycin, and ketoconazole.
  • To emphasize the importance of interdisciplinary communication in managing potential drug interactions.

Main Methods:

  • Case report of an epileptic patient.
  • Analysis of concurrent medication use (carbamazepine, erythromycin, ketoconazole).
  • Assessment of potential pharmacokinetic interactions based on known drug metabolism pathways.

Main Results:

  • The patient developed neurotoxicity while on high-dose carbamazepine monotherapy.
  • Concurrent use of erythromycin and ketoconazole likely inhibited carbamazepine metabolism.
  • This pharmacokinetic interaction led to elevated carbamazepine levels and toxicity.

Conclusions:

  • Drug interactions involving medications prescribed by different specialists can lead to severe adverse events.
  • Physicians must be aware of potential interactions, particularly with drugs affecting cytochrome P450 enzymes.
  • Interprofessional collaboration and comprehensive medication review are crucial for patient safety.